Michael Charles Ryan - Net Worth and Insider Trading

Michael Charles Ryan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Charles Ryan owns 1 companies in total, including Kiromic BioPharma Inc (KRBP) .

Click here to see the complete history of Michael Charles Ryan’s form 4 insider trades.

Insider Ownership Summary of Michael Charles Ryan

Ticker	Comapny	Transaction Date	Type of Owner
KRBP	Kiromic BioPharma Inc	2021-07-01	Chief Technology Officer

Michael Charles Ryan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Charles Ryan Ownership Network

Ownership Network List of Michael Charles Ryan

No Data

Ownership Network Relation of Michael Charles Ryan

Michael Charles Ryan Owned Company Details

What does Kiromic BioPharma Inc do?

Who are the key executives at Kiromic BioPharma Inc?

Michael Charles Ryan is the Chief Technology Officer of Kiromic BioPharma Inc. Other key executives at Kiromic BioPharma Inc include CFO Brian Hungerford , Interim CFO Daniel Grant Clark , and director & Chairman & CEO & and President Internati Maurizio Chiriva .

Kiromic BioPharma Inc (KRBP) Insider Trades Summary

Over the past 18 months, Michael Charles Ryan made no insider transaction in Kiromic BioPharma Inc (KRBP). Other recent insider transactions involving Kiromic BioPharma Inc (KRBP) include a net purchase of 8,000 shares made by Brian Hungerford , a net purchase of 9,488 shares made by Pietro Bersani , and a net purchase of 3,311 shares made by Pamela Misajon .

In summary, during the past 3 months, insiders sold 0 shares of Kiromic BioPharma Inc (KRBP) in total and bought 7,488 shares, with a net purchase of 7,488 shares. During the past 18 months, 0 shares of Kiromic BioPharma Inc (KRBP) were sold and 21,799 shares were bought by its insiders, resulting in a net purchase of 21,799 shares.

Kiromic BioPharma Inc (KRBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kiromic BioPharma Inc Insider Transactions

No Available Data

Michael Charles Ryan Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Charles Ryan. You might contact Michael Charles Ryan via mailing address: 7707 Fannin, Suite 140, Houston Tx 77054.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.